|
1
|
Breyer B, Jiang W, Cheng H, et al:
Adenoviral vector-mediated gene transfer for human gene therapy.
Curr Gene Ther. 1:149–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim M, Zinn KRB, Barnett G, et al: The
therapeutic efficacy of adenoviral vectors for cancer gene therapy
is limited by a low level of primary adenovirus receptors on tumour
cells. Eur J Cancer. 38:1917–1926. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wickham TJ, Roelvink PW, Brough, et al:
Adenovirus targeted to heparan-containing receptors increases its
gene delivery efficiency to multiple cell types. Nat Biotechnol.
14:1570–1573. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krasnykh VN, Mikheeva GV, Douglas JT, et
al: Generation of recombinant adenovirus vectors with modified
fibers for altering viral tropism. J Virol. 70:6839–6846.
1996.PubMed/NCBI
|
|
5
|
Tomko RP, Xu R and Philipson L: HCAR and
MCAR: the human and mouse cellular receptors for subgroup C
adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA.
94:3352–3356. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bergelson JM, Cunningham JA, Droguett G,
et al: Isolation of a common receptor for coxsackie B viruses and
adenoviruses 2 and 5. Science. 275:1320–1323. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bergelson JM, Krithivas A, Celi L, et al:
The murine CAR homolog is a receptor for coxsackie B viruses and
adenoviruses. J Virol. 72:415–419. 1998.PubMed/NCBI
|
|
8
|
Roelvink PW, Lizonova A, Lee JG, et al:
The coxsackievirus-adenovirus receptor protein can function as a
cellular attachment protein for adenovirus serotypes from subgroups
A, C, D, E and F. J Virol. 72:7909–7915. 1998.PubMed/NCBI
|
|
9
|
Wickham TJ, Matthias P, Cheresh DA, et al:
Integrins αvβ3 and αvβ5
promote adenovirus internalization but not virus attachment. Cell.
73:309–319. 1993.
|
|
10
|
Nemerow GR, Pache L, Reddy V and Stewart
PL: Insights into adenovirus host cell interactions from structural
studies. Virology. 384:380–388. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eto Y, Gao JQ, Sekiguchi F, et al:
PEGylated adenovirus vectors containing RGD peptides on the tip of
PEG show high transduction efficiency and antibody evasion ability.
J Gene Med. 7:604–612. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wortmann A, Vöhringer S, Engler T, et al:
Fully detargeted polyethylene glycol-coated adenovirus vectors are
potent genetic vaccines and escape from pre-existing
anti-adenovirus antibodies. Mol Ther. 16:154–162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakurai F, Mizuguchi H and Hayakawa T:
Efficient gene transfer into human CD34+ cells by an
adenovirus type 35 vector. Gene Ther. 10:1041–1048. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wohlfahrt ME, Beard BC, Lieber A and Kiem
HP: A capsid-modified, conditionally replicating oncolytic
adenovirus vector expressing TRAIL leads to enhanced cancer cell
killing in human glioblastoma models. Cancer Res. 67:8783–8790.
2007. View Article : Google Scholar
|
|
15
|
Havenga MJ, Lemckert AA, Grimbergen JM, et
al: Improved adenovirus vectors for infection of cardiovascular
tissues. J Virol. 75:3335–3342. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goossens PH, Havenga MJ, Pieterman E, et
al: Infection efficiency of type 5 adenoviral vectors in synovial
tissue can be enhanced with a type 16 fiber. Arthritis Rheum.
44:570–577. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia H, Anderson B, Mao Q and Davidson BL:
Recombinant human adenovirus: targeting to the human transferrin
receptor improves gene transfer to brain microcapillary
endothelium. J Virol. 74:11359–11366. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rittner K, Schreiber V, Erbs P and Lusky
M: Targeting of adenovirus vectors carrying a tumor cell-specific
peptide: in vitro and in vivo studies. Cancer Gene
Ther. 14:509–518. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jullienne B, Vigant F, Muth E, et al:
Efficient delivery of angiostatin K1–5 into tumors following
insertion of an NGR peptide into adenovirus capsid. Gene Ther.
16:1405–1415. 2009.PubMed/NCBI
|
|
20
|
Liu S, Mao Q, Zhang W, et al: Genetically
modified adenoviral vector with the protein transduction domain of
Tat improves gene transfer to CAR-deficient cells. Biosci Rep.
29:103–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Di B, Mao Q, Zhao J, et al: A rapid
generation of adenovirus vector with a genetic modification in
hexon protein. J Biotechnol. 157:373–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giordano RJ, Cardó-Vila M, Lahdenranta J,
et al: Biopanning and rapid analysis of selective interactive
ligands. Nat Med. 7:1249–1253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alexander BL, Ali RR, Alton EW, et al:
Progress and prospects: gene therapy clinical trials (part 1). Gene
Ther. 14:1439–1447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aiuti A, Bachoud-Lévi AC, Blesch A, et al:
Progress and prospects: gene therapy clinical trials (part 2). Gene
Ther. 14:1555–1563. 2007. View Article : Google Scholar
|
|
25
|
Volpers C, Thirion C, Biermann V, et al:
Antibody-mediated targeting of an adenovirus vector modified to
contain a synthetic immunoglobulin g-binding domain in the capsid.
J Virol. 77:2093–2104. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haisma HJ, Grill J, Curiel DT, et al:
Targeting of adenoviral vectors through a bispecific single-chain
antibody. Cancer Gene Ther. 7:901–904. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arap W, Pasqualini R and Ruoslahti E:
Cancer treatment by targeted drug delivery to tumor vasculature in
a mouse model. Science. 279:377–380. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Curnis F, Arrigoni G, Sacchi A, et al:
Differential binding of drugs containing the NGR motif to CD13
isoforms in tumor vessels, epithelia, and myeloid cells. Cancer
Res. 62:867–874. 2002.PubMed/NCBI
|
|
29
|
Pasqualini R, Koivunen E, Kain R, et al:
Aminopeptidase N is a receptor for tumor-homing peptides and a
target for inhibiting angiogenesis. Cancer Res. 60:722–727.
2000.PubMed/NCBI
|
|
30
|
Rasmussen UB, Schreiber V, Schultz H, et
al: Tumor cell-targeting by phage-displayed peptides. Cancer Gene
Ther. 9:606–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Belousova N, Krendelchtchikova V, Curiel
DT and Krasnykh V: Modulation of adenovirus vector tropism via
incorporation of polypeptide ligands into the fiber protein. J
Virol. 76:8621–8631. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vigne E, Mahfouz I, Dedieu JF, et al: RGD
inclusion in the hexon monomer provides adenovirus type 5-based
vectors with a fiber knob-independent pathway for infection. J
Virol. 73:5156–5161. 1999.PubMed/NCBI
|
